Free Trial

NewGenIvf Group (NIVF) Competitors

NewGenIvf Group logo
$1.79 -0.19 (-9.60%)
As of 04:00 PM Eastern

NIVF vs. ACON, BACK, BTTX, UPHL, ACONW, AONC, DHACW, LFMDP, OTRKP, and PIIIW

Should you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include Aclarion (ACON), IMAC (BACK), Better Therapeutics (BTTX), UpHealth (UPHL), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), and P3 Health Partners (PIIIW). These companies are all part of the "healthcare" industry.

NewGenIvf Group vs. Its Competitors

NewGenIvf Group (NASDAQ:NIVF) and Aclarion (NASDAQ:ACON) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, community ranking, earnings, risk, media sentiment, analyst recommendations and institutional ownership.

66.2% of NewGenIvf Group shares are owned by institutional investors. Comparatively, 7.5% of Aclarion shares are owned by institutional investors. 31.8% of NewGenIvf Group shares are owned by company insiders. Comparatively, 0.8% of Aclarion shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

NewGenIvf Group has higher revenue and earnings than Aclarion.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NewGenIvf Group$5.43M0.17$130KN/AN/A
Aclarion$54.60K78.98-$4.91MN/AN/A

In the previous week, NewGenIvf Group and NewGenIvf Group both had 2 articles in the media. Aclarion's average media sentiment score of 1.43 beat NewGenIvf Group's score of 1.23 indicating that Aclarion is being referred to more favorably in the news media.

Company Overall Sentiment
NewGenIvf Group Positive
Aclarion Positive

Aclarion received 4 more outperform votes than NewGenIvf Group when rated by MarketBeat users.

CompanyUnderperformOutperform
NewGenIvf GroupN/AN/A
AclarionOutperform Votes
4
57.14%
Underperform Votes
3
42.86%

NewGenIvf Group has a beta of 0.13, suggesting that its stock price is 87% less volatile than the S&P 500. Comparatively, Aclarion has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500.

Aclarion has a consensus target price of $11,758.50, indicating a potential upside of 158,584.21%. Given Aclarion's stronger consensus rating and higher possible upside, analysts clearly believe Aclarion is more favorable than NewGenIvf Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NewGenIvf Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Aclarion
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

NewGenIvf Group has a net margin of 0.00% compared to Aclarion's net margin of -12,845.05%. NewGenIvf Group's return on equity of 0.00% beat Aclarion's return on equity.

Company Net Margins Return on Equity Return on Assets
NewGenIvf GroupN/A N/A N/A
Aclarion -12,845.05%-422.87%-201.15%

Summary

NewGenIvf Group beats Aclarion on 7 of the 13 factors compared between the two stocks.

Get NewGenIvf Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for NIVF and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NIVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NIVF vs. The Competition

MetricNewGenIvf Grouphealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ Exchange
Market Cap$1.04M$2.01B$5.61B$8.62B
Dividend YieldN/A7.21%5.28%4.17%
P/E RatioN/A16.1727.1419.96
Price / Sales0.174.52411.83157.63
Price / Cash3.119.3238.2534.64
Price / Book0.823.967.064.69
Net Income$130K$87.49M$3.23B$248.14M
7 Day Performance-22.17%3.80%2.67%2.39%
1 Month Performance-43.89%-1.71%8.82%6.05%
1 Year Performance-99.21%-16.44%31.44%13.60%

NewGenIvf Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NIVF
NewGenIvf Group
2.1897 of 5 stars
$1.79
-9.6%
N/A-99.1%$1.04M$5.43M0.00N/ANews Coverage
Positive News
High Trading Volume
ACON
Aclarion
2.5004 of 5 stars
$7.13
+3.8%
$11,758.50
+164,815.8%
-99.7%$4.00M$54.60K0.007Positive News
Short Interest ↓
BACK
IMAC
N/A$0.04
+8.5%
N/A-98.1%$92K$72.05K0.00180Gap Up
BTTX
Better Therapeutics
N/A$0.00
flat
N/A-98.9%$5KN/A0.0040
UPHL
UpHealth
N/A$0.00
flat
N/A-100.0%$4K$130M0.001,750
ACONW
Aclarion
N/A$0.04
-0.3%
N/A+16.7%$0.00$54.60K0.007Positive News
Gap Up
AONC
American Oncology Network
N/A$11.46
+6.1%
N/A+653.4%$0.00$1.34B0.001,520High Trading Volume
DHACW
Digital Health Acquisition
N/A$0.05
flat
N/AN/A$0.00N/A0.00N/A
LFMDP
LifeMD
N/A$23.46
+0.7%
N/A+6.0%$0.00$234.01M0.00230Positive News
Short Interest ↓
Gap Up
OTRKP
Ontrak
N/A$0.24
+8.5%
N/A-31.5%$0.00$10.84M0.00250Gap Up
PIIIW
P3 Health Partners
N/A$0.01
-1.9%
N/AN/A$0.00$1.49B0.00500Gap Down

Related Companies and Tools


This page (NASDAQ:NIVF) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners